Co‐expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer
PROTEOMICS – Clinical Applications · 2019-11 · 13 (6)
DOI: 10.1002/prca.201900017 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 23.08.2019. Verfasst von Wang Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Surgery, The Second Hospital of Jilin University, Changchun, 130041, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
Intense efforts have been made in colorectal cancer (CRC) treatment in recent decades. However, the mechanism of development and metastasis of CRC has not been fully cleared. This study is designed to identify key proteins involved in stage III and hepatic metastatic CRC. Experiment design Protein expression profiles of paired tumor and benign tissue samples from stage III and hepatic metastatic CRC patients are characterized by using a label‐free proteomics approach. Key proteins relevant to hepatic metastatic CRC are revealed by weighted gene correlation network analysis (WGCNA) and other bioinformatics tools.
Results
WGCNA reveals three hub modules: CRC without specific stage (turquoise), stage III CRC (blue), and hepatic metastatic CRC (green). Nine key proteins (heat shock protein family D member 1 (HSPD1), eukaryotic translation elongation factor 1 gamma, heterogeneous nuclear ribonucleoprotein A2/B1, fibrinogen beta chain (FGB), Talin 1, adaptor related protein complex 2 subunit alpha 2, serrate RNA effector molecule homolog, apolipoprotein C3, phosphoglucomutase 5) are identified. Moreover, upregulation of HSPD1 is validated in CRC tissue by the immunohistochemistry. Upregulation of fibrinogen is validated in metastatic CRC by plasma fibrinogen assay. Conclusion and clinical relevance This study provides the proteomic analysis of stage III and hepatic metastatic CRC to identify key proteins of CRC. FGB plays a key role to serve as diagnostic and therapeutic biomarkers for hepatic metastatic CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Surgery, The Second Hospital of Jilin University, Changchun, 130041, China.
- College of Clinical Medicine, Jilin University, Changchun, 130012, China.
- Gastrointestinal Surgery, The Second Affiliated Hospital of Shandong University, Jinan, 250033, China.
- Institute of Liver Diseases, Affiliated Hospital of Jining Medical University, Jining, 272067, P. R. China.
- Central Laboratory, The Second Hospital of Jilin University, Changchun, 130041, China.
- Key Laboratory of Zoonosis Research, Ministry of Education, Jilin University, Changchun, 130062, China.
ORCID-Profile: Wang Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, W., Shi, J., Zhou, Y., Liu, T., Li, J., Hong, F., Zhang, K., & Liu, N. (2019). Co‐expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer. PROTEOMICS – Clinical Applications, 13(6). https://doi.org/10.1002/prca.201900017
Vancouver
Yang W, Shi J, Zhou Y, Liu T, Li J, Hong F, et al. Co‐expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer. PROTEOMICS – Clinical Applications. 2019;13(6). doi:10.1002/prca.201900017
BibTeX
@article{Yang2019,
author = {Yang, Wang and Shi, Jian and Zhou, Yan and Liu, Tongjun and Li, Jiannan and Hong, Feng and Zhang, Kai and Liu, Ning},
title = {Co‐expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer},
journal = {PROTEOMICS – Clinical Applications},
year = {2019},
volume = {13},
number = {6},
doi = {10.1002/prca.201900017}
}
EUVIMED